the Safety, Tolerability, and Pharmacokinetics Study of HEC113995

Clinical trial NCT04623814 · COMPLETED

Trial details

NCT number: NCT04623814
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2020-03-30
Primary completion: 2020-08-12
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.